Skip to main content
. 2022 Jul 20;12:20–29. doi: 10.1016/j.xjon.2022.07.005

Table 5.

Intraoperative data

Variable Total (N = 497) No-ABT (n = 100) ABT (n = 397) P value PSM-No-ABT (n = 89) PSM–ABT (n = 89) P value
Aortic root procedure .82 .82
 None 36 (7.2) 9 (9.0) 27 (6.8) .45 8 (9.0) 5 (5.6) .39
 AVR only 12 (2.4) 2 (2.0) 10 (2.5) .76 2 (2.2) 1 (1.1) .56
 Root replacement 153 (31) 33 (33) 120 (30) .59 29 (33) 27 (30) .75
 Root repair 296 (60) 56 (56) 240 (60) .42 50 (56) 56 (63) .36
Arch replacement .14 .23
 None 22 (4.4) 4 (4.0) 18 (4.5) .82 3 (3.4) 6 (6.7) .30
 Hemiarch 309 (62) 64 (64) 245 (62) .67 56 (63) 58 (65) .75
 Zone 1 Arch 46 (9.3) 3 (3.0) 43 (11) .02 3 (3.4) 8 (9.0) .12
 Zone 2 Arch 91 (18) 23 (23) 68 (17) .17 22 (25) 13 (15) .09
 Zone 3 Arch 29 (5.8) 6 (6.0) 23 (5.8) .94 5 (5.6) 4 (4.5) .73
Frozen elephant trunk 99 (20) 16 (16) 83 (21) .27 14 (16) 18 (20) .43
Concomitant procedures
 CABG 25 (5.0) 6 (6.0) 19 (4.8) .62 5 (5.6) 6 (6.7) .76
 Mitral valve 8 (1.6) 1 (1.0) 7 (1.8) .59 0 (0) 1 (1.1) .32
 Tricuspid valve 6 (1.2) 1 (1.0) 5 (1.3) .83 0 (0) 1 (1.1) .32
CPB time (min) 218 (177, 269) 227 (183, 289) 217 (176, 265) .15 227 (191, 289) 217 (182, 253) .19
Crossclamp time (min) 142 (110, 198) 148 (116, 195) 142 (109, 199) .53 150 (120, 192) 139 (110, 196) .50
HCA 477 (96) 96 (96) 381 (96) .99 86 (97) 84 (94) .47
 HCA time (min) 30 (22, 39) 29 (23, 42) 31 (22, 39) .89 30 (23, 43) 31 (24, 38) .66
Cerebral perfusion .97 .79
 None 20 (4.0) 4 (4.0) 16 (4.0) .99 3 (3.4) 5 (5.6) .47
 Antegrade 308 (62) 64 (64) 244 (61) .64 59 (66) 56 (63) .64
 Retrograde 117 (24) 22 (22) 95 (24) .68 18 (20) 21 (24) .59
 Both antegrade and retrograde 52 (10) 10 (10) 42 (11) .87 9 (10) 7 (7.9) .60
Lowest temperature (°C) 20 (18, 24) 19 (18, 24) 20 (18, 24) .43 18.5 (18, 24) 19.8 (18, 24) .37
Lowest HCT (%) on CPB 21 (18, 23) 20 (18, 24) 21 (19, 23) .06 20 (18, 24) 21 (18, 23) .92
Any blood products 390 (79) 92 (92) 298 (75) <.001 81 (91) 73 (82) .12
Blood transfused (U) 6.0 (1.0, 11) 12 (6.5, 18) 4.0 (1.0, 9.0) <.0001 11 (5.0, 17) 6.0 (2.0, 11) <.0001
 PRBCs 305 (61) 84 (84) 221 (56) <.001 73 (82) 63 (71) .11
 PRBCs (U) 1.0 (0.0, 4.0) 4.0 (1.0, 8.0) 1.0 (0.0, 3.0) <.0001 4.0 (1.0, 8.0) 2.0 (0.0, 4.0) .001
 FFP 287 (58) 81 (81) 206 (52) <.001 71 (80) 51 (57) .002
 FFP (U) 1.0 (0.0, 4.0) 4.0 (1.0, 8.0) 1.0 (0.0, 3.0) <.0001 4.0 (1.0, 6.0) 2.0 (0.0, 3.0) <.0001
 Platelets 330 (66) 85 (85) 245 (62) <.001 74 (83) 59 (66) .02
 Platelets (U) 2.0 (0.0, 3.0) 3.0 (1.0, 5.0) 2.0 (0.0, 3.0) <.0001 2.0 (1.0, 5.0) 2.0 (0.0, 4.0) .03
 Cryoprecipitate 171 (34) 55 (55) 116 (29) <.001 48 (54) 29 (33) .006
 Cryoprecipitate (U) 0.0 (0.0, 2.0) 1.0 (0.0, 2.0) 0.0 (0.0, 1.0) <.0001 1.0 (0.0, 2.0) 0.0 (0.0, 2.0) .005
Autologous blood volume (mL) 900 (900, 1350) 900 (900, 1350) 900 (450, 1350)
Activated factor VII 34 (6.8) 9 (9.0) 25 (6.3) .34 8 (8.9) 5 (5.6) .57

Values are presented as median (25%, 75%) for continuous data and n (%) for categorical data. Only patients who received blood transfusion. Bolded P values indicate statistical significance. ABT, Autologous blood transfusion; PSM, propensity score match; AVR, aortic valve replacement; CABG, coronary artery bypass graft; CPB, cardiopulmonary bypass; HCA, hypothermic circulatory arrest; HCT, hematocrit; PRBCs, packed red blood cells. FFP, fresh frozen plasma.

P values indicates the difference between autologous blood transfusion and no autologous blood transfusion groups.